ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 51 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q2 2019. The put-call ratio across all filers is 3.32 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $14,871 | +113.6% | 128,202 | +213.0% | 0.00% | – |
| Q4 2022 | $6,963 | -83.8% | 40,958 | -52.4% | 0.00% | – |
| Q2 2022 | $43,000 | +10.3% | 85,984 | +29.0% | 0.00% | – |
| Q1 2022 | $39,000 | -56.2% | 66,653 | -54.1% | 0.00% | – |
| Q4 2021 | $89,000 | +81.6% | 145,344 | +190.7% | 0.00% | – |
| Q3 2021 | $49,000 | -25.8% | 50,000 | -16.3% | 0.00% | – |
| Q2 2021 | $66,000 | +40.4% | 59,709 | +19.4% | 0.00% | – |
| Q1 2021 | $47,000 | +42.4% | 50,000 | -27.3% | 0.00% | – |
| Q4 2020 | $33,000 | +312.5% | 68,823 | +593.1% | 0.00% | – |
| Q3 2020 | $8,000 | -75.8% | 9,930 | -83.9% | 0.00% | – |
| Q2 2020 | $33,000 | +725.0% | 61,575 | +426.3% | 0.00% | – |
| Q1 2020 | $4,000 | -76.5% | 11,699 | -49.5% | 0.00% | – |
| Q4 2019 | $17,000 | +240.0% | 23,159 | +272.3% | 0.00% | – |
| Q3 2019 | $5,000 | -28.6% | 6,220 | +22.8% | 0.00% | – |
| Q2 2019 | $7,000 | -36.4% | 5,065 | 0.0% | 0.00% | – |
| Q1 2019 | $11,000 | 0.0% | 5,065 | 0.0% | 0.00% | – |
| Q4 2018 | $11,000 | -63.3% | 5,065 | -40.7% | 0.00% | – |
| Q3 2018 | $30,000 | -23.1% | 8,535 | -30.5% | 0.00% | – |
| Q2 2018 | $39,000 | +69.6% | 12,279 | +85.2% | 0.00% | – |
| Q1 2018 | $23,000 | +1050.0% | 6,629 | +1310.4% | 0.00% | – |
| Q4 2017 | $2,000 | -81.8% | 470 | -77.7% | 0.00% | – |
| Q3 2017 | $11,000 | +450.0% | 2,108 | +348.5% | 0.00% | – |
| Q2 2017 | $2,000 | 0.0% | 470 | 0.0% | 0.00% | – |
| Q1 2017 | $2,000 | -50.0% | 470 | -62.9% | 0.00% | – |
| Q4 2016 | $4,000 | +100.0% | 1,268 | +169.8% | 0.00% | – |
| Q3 2016 | $2,000 | +100.0% | 470 | -6.0% | 0.00% | – |
| Q2 2016 | $1,000 | -66.7% | 500 | -9.9% | 0.00% | – |
| Q1 2016 | $3,000 | 0.0% | 555 | -33.9% | 0.00% | – |
| Q3 2015 | $3,000 | -78.6% | 840 | -75.0% | 0.00% | – |
| Q2 2015 | $14,000 | – | 3,366 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Capital CS Group, LLC | 75,669 | $38,000 | 0.04% |
| Founders Capital Management | 18,000 | $9,000 | 0.01% |
| Verdence Capital Advisors LLC | 58,382 | $29,000 | 0.00% |
| WOLFF WIESE MAGANA LLC | 10,740 | $5,000 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 93,669 | $47,000 | 0.00% |
| Affinity Capital Advisors, LLC | 13,180 | $7,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 171,928 | $86,000 | 0.00% |
| B. Riley Wealth Advisors, Inc. | 25,210 | $13,000 | 0.00% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 100,000 | $50,000 | 0.00% |
| MGO ONE SEVEN LLC | 10,615 | $5,000 | 0.00% |